No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

New MAGA-leaning digital news outlet may feature the likes of controversial commentator Candace Owens and pro-Trump CNN ...

Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Wednesday following a better than expected earnings announcement. The company ...

Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a hold rating on the stock. ObsEva Price ...

Inc.'s stock has tumbled to a 52-week low, touching down at $2.6, a dramatic fall from its 52-week high of $74.5. According to InvestingPro analysis, the company's market capitalization has shrunk to ...

The Institute of Chemical Technology, Mumbai, in collaboration with the Mumbai Biocluster, successfully hosted the 5th Annual ...

European equities traded in the US as American depositary receipts were tracking slightly lower late Thursday morning, declining 0.04% to 1,402.70 on the S&P Europe Select ADR Index. From continental ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination ...